[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB9818914D0 - Use - Google Patents

Use

Info

Publication number
GB9818914D0
GB9818914D0 GBGB9818914.5A GB9818914A GB9818914D0 GB 9818914 D0 GB9818914 D0 GB 9818914D0 GB 9818914 A GB9818914 A GB 9818914A GB 9818914 D0 GB9818914 D0 GB 9818914D0
Authority
GB
United Kingdom
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9818914.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9818914.5A priority Critical patent/GB9818914D0/en
Publication of GB9818914D0 publication Critical patent/GB9818914D0/en
Priority to PCT/EP1999/006219 priority patent/WO2000012623A2/en
Priority to AU59706/99A priority patent/AU5970699A/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB9818914.5A 1998-08-28 1998-08-28 Use Ceased GB9818914D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9818914.5A GB9818914D0 (en) 1998-08-28 1998-08-28 Use
PCT/EP1999/006219 WO2000012623A2 (en) 1998-08-28 1999-08-25 Use of 5-th receptor antagonists for the treatment of parkinson's disease
AU59706/99A AU5970699A (en) 1998-08-28 1999-08-25 Use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9818914.5A GB9818914D0 (en) 1998-08-28 1998-08-28 Use

Publications (1)

Publication Number Publication Date
GB9818914D0 true GB9818914D0 (en) 1998-10-21

Family

ID=10838073

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9818914.5A Ceased GB9818914D0 (en) 1998-08-28 1998-08-28 Use

Country Status (3)

Country Link
AU (1) AU5970699A (en)
GB (1) GB9818914D0 (en)
WO (1) WO2000012623A2 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041691B1 (en) 1999-06-30 2006-05-09 Amgen Inc. Compounds for the modulation of PPARγ activity
PE20020063A1 (en) 2000-06-20 2002-01-30 Upjohn Co BIS-ARYLSULFONES AS LIGANDS OF THE 5-HT RECEPTOR
US6586592B2 (en) 2000-06-20 2003-07-01 Pharmacia & Upjohn Company Bis-arylsulfones
JP3847711B2 (en) * 2000-09-18 2006-11-22 トーアエイヨー株式会社 N-substituted benzothiophenesulfonamide derivatives
US7071220B2 (en) 2000-09-18 2006-07-04 Toa Eiyo Ltd. N-substituted benzothiophenesulfonamide derivatives
IL156595A0 (en) 2001-01-16 2004-01-04 Astrazeneca Ab Therapeutic heterocyclic compounds
MXPA03006268A (en) 2001-01-16 2003-09-22 Astrazeneca Ab Therapeutic chromone compounds.
JP4597480B2 (en) 2001-05-11 2010-12-15 プロキシマゲン・リミテッド Novel arylsulfonamide compounds for the treatment of obesity, type II diabetes and CNS diseases
US7718650B2 (en) 2001-05-11 2010-05-18 Biovitrum Ab Aryl sulfonamide compounds for treating obesity
IL159880A0 (en) 2001-08-10 2004-06-20 Hoffmann La Roche Arylsulfonyl derivatives with 5-ht6 receptor affinity
JP4452809B2 (en) * 2002-03-15 2010-04-21 トーアエイヨー株式会社 N-substituted benzothiophenesulfonamide derivatives
PA8802201A1 (en) * 2007-11-02 2009-06-23 Abbott Gmbh & Co Kg APPROPRIATE BENCENSULFONALIDE COMPOUNDS TO TREAT DISORDERS THAT RESPOND TO THE MODULATION OF SEROTONINE 5-HT6 RECEPTOR
RS53460B (en) 2008-10-23 2014-12-31 Vertex Pharmaceuticals Incorporated Modulators of cystic fibrosis transmembrane conductance regulator
CN102459200A (en) * 2009-04-30 2012-05-16 雅培股份有限两合公司 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
US8343959B2 (en) 2009-04-30 2013-01-01 Abbott Gmbh & Co. Kg N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
CA2759494A1 (en) 2009-04-30 2010-11-04 Abbott Gmbh & Co. Kg. Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
JP5718898B2 (en) 2009-04-30 2015-05-13 アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー N-phenyl- (piperazinyl or homopiperazinyl) -benzenesulfonamide or benzenesulfonyl-phenyl- (piperazine or homopiperazine) compounds suitable for treating disorders responsive to modulation of serotonin 5-HT6 receptors
WO2012059431A1 (en) 2010-11-01 2012-05-10 Abbott Gmbh & Co. Kg Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-ht6 receptor
WO2012059432A1 (en) 2010-11-01 2012-05-10 Abbott Gmbh & Co. Kg N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the 5-ht6 receptor
KR20160068799A (en) * 2013-10-25 2016-06-15 글락소스미스클라인 엘엘씨 Novel compounds
LT3448430T (en) * 2016-04-26 2023-07-25 H. Lundbeck A/S Use of an acetylcholinesterase inhibitor and idalopirdine for reducing falls in parkinson's disease patients

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9119932D0 (en) * 1991-09-18 1991-10-30 Glaxo Group Ltd Chemical compounds
US5939451A (en) * 1996-06-28 1999-08-17 Hoffmann-La Roche Inc. Use of sulfonamides
DZ2376A1 (en) * 1996-12-19 2002-12-28 Smithkline Beecham Plc New sulfonamide derivatives process for their preparation and pharmaceutical compositions containing them.
BR9810991A (en) * 1997-07-11 2000-08-08 Smithkline Beecham Plc New compounds
GB9801392D0 (en) * 1998-01-22 1998-03-18 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
WO2000012623A3 (en) 2000-08-24
WO2000012623A2 (en) 2000-03-09
AU5970699A (en) 2000-03-21

Similar Documents

Publication Publication Date Title
DE69909613D1 (en) Bicyclische hydroxamsäurederivate
DE69924108D1 (en) Offshore-bohrsystem
DE59912932D1 (en) Arylphenylsubstituierte cyclische ketoenole
DE69918845D1 (en) Polyketonlösung
DE69913545D1 (en) Pyrimidonderivate
PL343923A1 (en) New use
EA199900308A3 (en) Swichgear
DE69943409D1 (en) Fmcw-radar
DE69914921D1 (en) Phenyl-xanthinderivate
DE69904335D1 (en) Aminomethylcarbonsäurederivate
DE69835235D1 (en) Thermoplastische silikonelastomere
DE69940558D1 (en) Fluoromonomerpolymerisation
DE59903023D1 (en) Perorale wirkstoff-suspension
DE59914151D1 (en) Arylalkanoylpyridazine
GB9818914D0 (en) Use
DE69934603D1 (en) Elektrophotographischer photoconduktor
GB9814640D0 (en) New use
DE69915628D1 (en) Ritonavir-polymorph
DE69939823D1 (en) Endo-beta-n-acetylglukosaminidase
DE69938146D1 (en) Ptc-chip-thermistor
DE69904442D1 (en) Cyclohexandiol-derivate
DE59904407D1 (en) Chromanderivate
EP1059091A4 (en) Transmucous sorbefacients
EP1083910A4 (en) nrdE
DE69821502D1 (en) Boroskop

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)